c-Jun N-terminal kinase pathway inhibition in intracerebral hemorrhage

Delphine Michel-Monigadon1, Christophe Bonny, Lorenz Hirt

  • 1Department of Clinical Neuroscience, Neurology Service, Centre Hospitalier Universitaire Vaudois and Lausanne University, Lausanne, Switzerland.

Insights

The JNK inhibitor XG-102 reduced brain swelling and improved neurological function in mice with intracerebral hemorrhage (ICH). This suggests XG-102 could be a rapid treatment for stroke patients.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cerebrovascular Disease Research

Background:

  • The c-Jun N-terminal kinase (JNK) pathway is implicated in brain injury.
  • JNK inhibition with XG-102 shows neuroprotection in ischemic stroke models.
  • The efficacy of JNK inhibition in intracerebral hemorrhage (ICH) requires investigation.

Purpose of the Study:

  • To investigate the therapeutic effect of JNK inhibition by XG-102 in a mouse model of intracerebral hemorrhage (ICH).

Main Methods:

  • Intracerebral hemorrhage (ICH) was induced in mice via collagenase injection.
  • Animals received intravenous injections of XG-102 (100 microg/kg) three hours post-ICH.
  • Neurological outcomes were assessed daily, with sacrifice at 6 hours, 1, 2, or 5 days post-ICH.

Main Results:

  • XG-102 significantly improved neurological outcomes by day 1 (p < 0.01).
  • Lesion volume decreased by day 2 (29 +/- 11 vs. 39 +/- 5 mm(3); p < 0.05).
  • Hemispheric swelling was reduced (14 +/- 13 vs. 26 +/- 9%; p < 0.05), correlating with increased aquaporin 4 expression.

Conclusions:

  • XG-102 attenuates cerebral edema and functional deficits in early stages of ICH.
  • Beneficial effects in ICH, similar to ischemic stroke, suggest potential for rapid pre-imaging treatment in stroke patients.
Abstract

Related Concept Videos

Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...